On Writing Well

Although English is not my mother tongue, I am very concerned by the subject.1 As an editor of microbiological periodicals, I had [the need] sometimes to reject manuscripts of native English speakers because of poor grammar. French is under siege, too. For example, the new generation of Quebec scientists is often ignorant of basic principles of French grammar and even spelling.I am a virologist and a specialist of bacterial viruses. What galls me particularly is the increasing use of "bacterioph

Written byHans Ackermann
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Although English is not my mother tongue, I am very concerned by the subject.1 As an editor of microbiological periodicals, I had [the need] sometimes to reject manuscripts of native English speakers because of poor grammar. French is under siege, too. For example, the new generation of Quebec scientists is often ignorant of basic principles of French grammar and even spelling.

I am a virologist and a specialist of bacterial viruses. What galls me particularly is the increasing use of "bacteriophage" or "phage" as an invariable word, although there is a good plural (bacteriophages, phages). Certainly, such invariable words exist in the new English language, but they are rare. The invariable "phage" was first used in 1920. Now it is used again, generally by inexperienced people, and just generates loose writing.

I agree that we need style editors and terminology regulations.

Hans-W. Ackermann, MD

Professor, University Laval Quebec ackermann@mcb.ulaval.ca

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies